Treatment of type 2 diabetes with rosiglitazone associated with increased risk of cardiovascular events among older adults

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:79 / 80
页数:2
相关论文
共 50 条
  • [21] Alcohol consumption and type 2 diabetes among older adults:: The cardiovascular health study
    Djousse, Luc
    Biggs, Mary L.
    Mukamal, Kenneth J.
    Siscovick, David S.
    OBESITY, 2007, 15 (07) : 1758 - 1765
  • [22] Factors Associated with Increased Bone fracture Risk among Older Male Veterans with Type 2 Diabetes Mellitus
    Lee, Richard H.
    Sloane, Richard
    Colon-Emeric, Cathleen
    DIABETES, 2016, 65 : A362 - A363
  • [23] Fetuin-A, Type 2 Diabetes, and Risk of Cardiovascular Disease in Older Adults The Cardiovascular Health Study
    Jensen, Majken K.
    Bartz, Traci M.
    Mukamal, Kenneth J.
    Djousse, Luc
    Kizer, Jorge R.
    Tracy, Russell P.
    Zieman, Susan J.
    Rimm, Eric B.
    Siscovick, David S.
    Shlipak, Michael
    Ix, Joachim H.
    DIABETES CARE, 2013, 36 (05) : 1222 - 1228
  • [24] Reply to "Daytime napping and risk of incident main adverse cardiovascular events and mortality among adults with type 2 diabetes"
    Yang, Xiu Hong
    Liu, Yao
    Jiang, Xin Xin
    Zhang, Zhen Xing
    Lu, Yi Jun
    Fu, Chen Sheng
    Jin, Hui Min
    Bin Ye, Zhi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 223
  • [25] Risk factors associated with falls among older adults with diabetes
    Hassan, D. Alsayed
    Chivese, T.
    Syed, M.
    Al-Sayed, G.
    Sharshani, H.
    Al Muraikhi, M.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2023, 33
  • [26] Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
    Irons, BK
    Greene, RS
    Mazzolini, TA
    Edwards, KL
    Sleeper, RB
    PHARMACOTHERAPY, 2006, 26 (02): : 168 - 181
  • [27] No increased risk of cardiovascular events with dapagliflozin in elderly patients with type 2 diabetes mellitus, cardiovascular disease and hypertension
    Gause-Nilsson, I.
    Sonesson, C.
    Johansson, P. A.
    Johnsson, E.
    DIABETOLOGIA, 2015, 58 : S362 - S363
  • [28] No Increased Risk of Cardiovascular Events with Dapagliflozin in Elderly Patients with Type 2 Diabetes Mellitus, Cardiovascular Disease, and Hypertension
    Gause-Nilsson, Ingrid Ami
    Sonesson, Christian
    Johansson, Peter A.
    Sugg, Jennifer E.
    Johnsson, Eva
    DIABETES, 2015, 64 : A4 - A4
  • [29] Blood adiponectin levels are not associated with risk of cardiovascular events in patients with type 2 diabetes
    Jeon, Ja Young
    Ha, Kyoung Hwa
    Han, Seung Jin
    Kim, Hae Jin
    Lee, Kwan-Woo
    Kim, Dae Jung
    DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (06): : 571 - 575
  • [30] Falls Risk in Older Adults with Type 2 Diabetes
    Vinik, Aaron I.
    Vinik, Etta J.
    Colberg, Sheri R.
    Morrison, Steven
    CLINICS IN GERIATRIC MEDICINE, 2015, 31 (01) : 89 - +